Information regarding Coronavirus Disease

News

BOL Pharma’s center for growing medicinal cannabinoid.

Miller School Collaborates with BOL Pharma to Pioneer Research on Using CBD to Treat Concussion

One of the few manufacturers in the world that meets the high-quality research standards in the U.S. and Europe for medicinal cannabinoid (CBD) is collaborating with University of Miami Miller School of Medicine researchers, providing the company’s product for groundbreaking studies.

Read more about the research »

Dr. Murray Epstein

COVID-19 Alert: Heart and Kidney Patients Should Keep Taking Their Medicines

As the COVID-19 pandemic unfolds, inaccurate medical information has flooded social media and other channels. One potentially lethal example is that patients who take renin-angiotensin system (RAS) blockers, particularly angiotensin II type 1 receptor blockers (ARBs), may be more susceptible to the virus.

Read more about COVID-19 »

Dr. Sylvia Daunert, center, with colleagues in her lab.

University of Miami to Develop COVID-19 Rapid Diagnostic Test in Collaboration with Heat Biologics

Biomedical researchers at the University of Miami Miller School of Medicine are developing a COVID-19 point-of-care diagnostic test in collaboration with biopharmaceutical company Heat Biologics, Inc.

Read more about the COVID-19 test »

Emilie Fowler was accepted into a dermatology residency at UCLA.

Miller School Students Celebrate Match Day with Families and Friends

Natalia Parra was nervous about where she would be placed for an obstetrics-gynecology residency after earning her medical degree at the University of Miami Miller School of Medicine. “This is the next step in my career, and all my studies have led to this point,” she said, before learning she would be going to New York Presbyterian Hospital-Columbia University Medical Center in New York.

Read more about Match Day »

Dr. Nestor Villamizar (left) and Dr. Dao Nguyen.

Survival after Lung Cancer Surgery Similar in Comparison of Segmentectomy with Lobectomy

Traditionally, many surgeons performing a segmentectomy to remove a limited portion of the lung affected by cancer will switch to a lobectomy – removal of an entire lobe of the lung – during surgery if nearby lymph nodes also test positive for cancer.

Read more about the research »

News Archives

Office of the Dean

A message from the dean

Physician News

Read Med News

e-Update

Read e-Update